Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reverse phase protein microarrays advance to use in clinical trials

11 Oct 2010

Abstract excerpt

Individualizing cancer therapy for molecular targeted inhibitors requires a new class of molecular profiling technology that can map the functional state of the cancer cell signal pathways containing the drug targets. Reverse phase protein microarrays (RPMA) are a technology platform designed for quantitative, multiplexed analysis of specific phosphorylated, cleaved, or total (phosphorylated and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Biosensing Techniques and Applications
Share to Glycosylation and Glycoproteins Research
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20974554
DOI: 10.1016/j.molonc.2010.09.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reverse phase protein microarrays advance to use in clinical trialsPMID 20974554Read ↗

Reverse-phase protein microarrays: application to biomarker discovery and translational medicineSemantic proximity Read ↗

Monitoring proteins and protein networks using reverse phase protein arrays.Semantic proximity Read ↗

Protein microarrays: Molecular profiling technologies for clinical specimensSemantic proximity Read ↗

Multicenter reverse-phase protein array data integrationSemantic proximity Read ↗

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays.Semantic proximity Read ↗

Use of Reverse Phase Protein Microarrays and Reference Standard Development for Molecular Network Analysis of Metastatic Ovarian CarcinomaSemantic proximity Read ↗

Protein microarray platforms for clinical proteomics.Semantic proximity Read ↗

New technologies in cancer. Protein microarrays for biomarker discoverySemantic proximity Read ↗

Integrating Functional Protein Drug Target Data into a Precision Oncology Molecular Tumor BoardSemantic proximity Read ↗

Mapping Molecular Networks Using Proteomics: A Vision for Patient-Tailored Combination TherapySemantic proximity Read ↗

Mining the tumor phosphoproteome for cancer markers.Semantic proximity Read ↗

Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.